Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy

Total article views   HTML views PDF downloads Totals
4,954 Dovepress* 4,557+ 847 5,404
PubMed Central* 397 160 557
Totals 4,954 1,007 5,961
*Since 29 October 2020

View citations on PubMed Central and Google Scholar